| Year |
Citation |
Score |
| 2023 |
Xie H, Li X, Xu G, Huo C, Fan Y, Li Z, Dou Z. Effects of transcranial magnetic stimulation on dynamic functional networks in stroke patients as assessed by functional near-infrared spectroscopy: a randomized controlled clinical trial. Cerebral Cortex (New York, N.Y. : 1991). PMID 37885140 DOI: 10.1093/cercor/bhad404 |
0.323 |
|
| 2023 |
Qin Y, Li X, Qiao Y, Zou H, Qian Y, Li X, Zhu Y, Huo W, Wang L, Zhang M. DTI-ALPS: An MR biomarker for motor dysfunction in patients with subacute ischemic stroke. Frontiers in Neuroscience. 17: 1132393. PMID 37065921 DOI: 10.3389/fnins.2023.1132393 |
0.313 |
|
| 2022 |
Zhang J, Huang WH, Zheng YD, Li X, Jiang HX, Su MZ, Huang XY, Dou ZL, Tang ZM. Effects of auricular acupuncture stimulation on healthy adults' upper limb motor-evoked potentials: A randomized, crossover, double-blind study. Frontiers in Neuroscience. 16: 895602. PMID 36061611 DOI: 10.3389/fnins.2022.895602 |
0.303 |
|
| 2022 |
Huang W, Chen J, Zheng Y, Zhang J, Li X, Su L, Li Y, Dou Z. The Effectiveness of Intermittent Theta Burst Stimulation for Stroke Patients With Upper Limb Impairments: A Systematic Review and Meta-Analysis. Frontiers in Neurology. 13: 896651. PMID 35873775 DOI: 10.3389/fneur.2022.896651 |
0.361 |
|
| 2022 |
Mohan A, Knutson JS, Cunningham DA, Widina M, O'Laughlin K, Arora T, Li X, Sakaie K, Wang X, Uchino K, Plow EB. Contralaterally Controlled Functional Electrical Stimulation Combined With Brain Stimulation for Severe Upper Limb Hemiplegia-Study Protocol for a Randomized Controlled Trial. Frontiers in Neurology. 13: 869733. PMID 35599736 DOI: 10.3389/fneur.2022.869733 |
0.666 |
|
| 2022 |
Li X, Lin YL, Cunningham DA, Wolf SL, Sakaie K, Conforto AB, Machado AG, Mohan A, O'Laughlin K, Wang X, Widina M, Plow EB. Repetitive Transcranial Magnetic Stimulation of the Contralesional Dorsal Premotor Cortex for Upper Extremity Motor Improvement in Severe Stroke: Study Protocol for a Pilot Randomized Clinical Trial. Cerebrovascular Diseases (Basel, Switzerland). 1-8. PMID 35051941 DOI: 10.1159/000521514 |
0.705 |
|
| 2019 |
Li X, Morton SM. Effects of chronic antidepressant use on neurophysiological responses to tDCS post-stroke. Neuroscience Letters. 134723. PMID 31881255 DOI: 10.1016/J.Neulet.2019.134723 |
0.636 |
|
| 2019 |
Li X, Charalambous CC, Reisman DS, Morton SM. A short bout of high-intensity exercise alters ipsilesional motor cortical excitability post-stroke. Topics in Stroke Rehabilitation. 1-7. PMID 31144609 DOI: 10.1080/10749357.2019.1623458 |
0.738 |
|
| 2018 |
Charalambous CC, Alcantara CC, French MA, Li X, Matt KS, Kim HE, Morton SM, Reisman DS. A single exercise bout and locomotor learning after stroke: physiological, behavioral, and computational outcomes. The Journal of Physiology. PMID 29569729 DOI: 10.1113/Jp275881 |
0.725 |
|
| 2018 |
Li X, Morton SM. Explicit Awareness does not Modulate Retrograde Interference Effects in Sequence Learning. Journal of Motor Behavior. 1-7. PMID 29336724 DOI: 10.1080/00222895.2017.1417818 |
0.523 |
|
| 2016 |
Çelik H, Bulut G, Han J, Graham GT, Minas TZ, Conn EJ, Hong S, Pauly GT, Hayran M, Li X, Özdemirli M, Ayhan A, Rudek MA, Toretsky JA, Üren A. Abstract 2446: Ezrin inhibition up-regulates stress response gene expression and blocks osteosarcoma metastasis Cancer Research. 76: 2446-2446. DOI: 10.1158/1538-7445.Am2016-2446 |
0.311 |
|
| 2014 |
Bam R, Edmondson RD, Stein CK, Li X, Ling W, Khan S, Shelton RS, Barlogie B, Yaccoby S. Sustained Growth of Primary Myeloma Cells in Coculture with Whole Donor Bone Marrow Is Associated with Induced Secretion of the Microenvironmental Mediator of Cytokinesis, Hemicentin-1 Blood. 124: 3403-3403. DOI: 10.1182/Blood.V124.21.3403.3403 |
0.307 |
|
| 2013 |
Bam R, Ling W, Khan S, Pennisi A, Venkateshaiah SU, Li X, van Rhee F, Usmani S, Barlogie B, Shaughnessy J, Epstein J, Yaccoby S. Role of Bruton's tyrosine kinase in myeloma cell migration and induction of bone disease. American Journal of Hematology. 88: 463-71. PMID 23456977 DOI: 10.1002/Ajh.23433 |
0.315 |
|
| 2013 |
Venkateshaiah SU, Khan S, Ling W, Bam R, Li X, van Rhee F, Usmani S, Barlogie B, Epstein J, Yaccoby S. NAMPT/PBEF1 enzymatic activity is indispensable for myeloma cell growth and osteoclast activity. Experimental Hematology. 41: 547-557.e2. PMID 23435312 DOI: 10.1016/j.exphem.2013.02.008 |
0.303 |
|
| 2013 |
Bam R, Venkateshaiah SU, Li X, Khan S, Ling W, Shelton RS, Zhang Q, Barlogie B, Epstein J, Yaccoby S. Inhibition Of BTK Activity In Myeloma Cells Within a Supportive Microenvironment Promotes Their Growth But Suppresses Metastasis Blood. 122: 4432-4432. DOI: 10.1182/Blood.V122.21.4432.4432 |
0.322 |
|
| 2013 |
Venkateshaiah SU, Bam R, Li X, Sharmin K, Wen L, Shelton RS, Teige I, Frendéus B, Barlogie B, Yaccoby S. Macrophages Activation By ICAM1 Antibody Combined With Lenalidomide Has Enhanced Anti-Myeloma Activity In a Supportive Microenvironment In Vivo and In Vitro Blood. 122: 1926-1926. DOI: 10.1182/Blood.V122.21.1926.1926 |
0.315 |
|
| 2012 |
Garg TK, Szmania SM, Khan JA, Hoering A, Malbrough PA, Moreno-Bost A, Greenway AD, Lingo JD, Li X, Yaccoby S, Suva LJ, Storrie B, Tricot G, Campana D, Shaughnessy JD, et al. Highly activated and expanded natural killer cells for multiple myeloma immunotherapy. Haematologica. 97: 1348-56. PMID 22419581 DOI: 10.3324/Haematol.2011.056747 |
0.317 |
|
| 2012 |
Upparahallivenkateshaiah S, Sharmin K, Wen L, Bam R, Li X, Yaccoby S. Upregulation of Lipid Metabolism Modulators in Myeloma Cells Underlines Their Progression in a Supportive Microenvironment and Linking Metabolic Pathways with Growth Signaling Blood. 120: 329-329. DOI: 10.1182/Blood.V120.21.329.329 |
0.305 |
|
| 2012 |
Li X, Ling W, Khan S, Venkateshaiah SU, Bam R, Barlogie B, Epstein J, Yaccoby S. HMOX1 Is a Targeted Therapy for Myeloma-Induced Bone Disease. Blood. 120: 2944-2944. DOI: 10.1182/Blood.V120.21.2944.2944 |
0.301 |
|
| 2012 |
Pal A, Li X, Huang W, Kleer CG. Abstract 14: CCN6 knockdown-induced epithelial to mesenchymal transition and invasion is mediated through upregulation of TGFβ type III receptor Cancer Research. 72: 14-14. DOI: 10.1158/1538-7445.Am2012-14 |
0.301 |
|
| 2011 |
Bam R, Ling W, Khan S, Pennisi A, Venkateshaiah SU, Li X, Williams R, van Rhee F, Nair B, Usmani S, Barlogie B, Shaughnessy JD, Epstein J, Yaccoby S. Cell Surface CXCR4 and BTK Expression Are Associated in Myeloma Cells and Osteoclast Precursors and Mediate Myeloma Cell Homing and Clonogenicity, and Osteoclastogenesis Blood. 118: 884-884. DOI: 10.1182/Blood.V118.21.884.884 |
0.316 |
|
| 2011 |
Venkateshaiah SU, Khan S, Ling W, John LS, Bam R, Li X, Yaccoby S. Stearoyl CoA Desaturase 1 (SCD1) Is Upregulated in Rapidly Growing Myeloma Cells and Is Required for Cell Proliferation Blood. 118: 3943-3943. DOI: 10.1182/Blood.V118.21.3943.3943 |
0.315 |
|
| 2011 |
Bam R, Ling W, Khan S, Venkateshaiah SU, Li X, van Rhee F, Nair B, Usmani S, Barlogie B, Shaughnessy JD, Epstein J, Anaissie EJ, Yaccoby S. Deregulated Cellular Iron Metabolism Factors Mediate Iron Overload in Myeloma Cells and Osteoclasts, and Promote Myeloma Growth and Bone Disease, Blood. 118: 3941-3941. DOI: 10.1182/Blood.V118.21.3941.3941 |
0.301 |
|
| 2010 |
Li X, Ling W, Khan S, Wang Y, Pennisi A, Barlogie B, Shaughnessy J, Yaccoby S. Systemically Injected Mesenchymal Stem Cells Traffic to Myelomatous Bone and Inhibit Bone Disease, and Intralesionally Promotes Bone Formation and Delays Myeloma Progression During the Disease Active Stage or Remission Blood. 116: 980-980. DOI: 10.1182/Blood.V116.21.980.980 |
0.304 |
|
| 2010 |
Bam R, Pennisi A, Li X, Khan S, Wang Y, Ling W, Barlogie B, Shaughnessy J, Yaccoby S. Bruton's Tyrosine Kinase (BTK) Is Indispensable for Myeloma Cell Migration towards SDF-1 and Induction of Osteoclastogenesis and Osteolytic Bone Disease Blood. 116: 447-447. DOI: 10.1182/Blood.V116.21.447.447 |
0.313 |
|
| 2010 |
Pennisi A, Li X, Barlogie B, PhD JS, Yaccoby S. Consequences of Intermittent PTH Treatment on Myeloma Growth, Bone Disease and Molecular Profiling of Whole Myelomatous Bone Blood. 116: 4063-4063. DOI: 10.1182/Blood.V116.21.4063.4063 |
0.303 |
|
| 2009 |
van Rhee F, Szmania SM, Dillon M, van Abbema AM, Li X, Stone MK, Garg TK, Shi J, Moreno-Bost AM, Yun R, Balasa B, Ganguly B, Chao D, Rice AG, Zhan F, et al. Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma. Molecular Cancer Therapeutics. 8: 2616-24. PMID 19723891 DOI: 10.1158/1535-7163.Mct-09-0483 |
0.303 |
|
| 2009 |
Pennisi A, Ling W, Li X, Khan S, Shaughnessy JD, Barlogie B, Yaccoby S. The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth. Blood. 114: 1803-12. PMID 19597185 DOI: 10.1182/Blood-2009-01-201954 |
0.302 |
|
| 2009 |
Li X, Loberg R, Liao J, Ying C, Snyder LA, Pienta KJ, McCauley LK. A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone. Cancer Research. 69: 1685-92. PMID 19176388 DOI: 10.1158/0008-5472.Can-08-2164 |
0.301 |
|
| 2008 |
Li X, Pennisi A, Yaccoby S. Role of decorin in the antimyeloma effects of osteoblasts. Blood. 112: 159-68. PMID 18436739 DOI: 10.1182/Blood-2007-11-124164 |
0.319 |
|
| 2008 |
Pennisi A, Ling W, Li X, Chen J, Khan S, Yaccoby S. The EphrinB2/EphB4 Axis Is Dysregulated in Osteoprogenitors from Myeloma Patients and Its Activation by EphrinB2-Fc or EhpB4-Fc Affects Myeloma Bone Disease and Tumor Growth in Vivo Blood. 112: 844-844. DOI: 10.1182/Blood.V112.11.844.844 |
0.306 |
|
| 2007 |
Li X, Qin L, Bergenstock M, Bevelock LM, Novack DV, Partridge NC. Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre/osteoclasts. The Journal of Biological Chemistry. 282: 33098-106. PMID 17690108 DOI: 10.1074/Jbc.M611781200 |
0.303 |
|
| 2007 |
Li X, Pennisi A, Yaccoby S. Small Leucine-Rich Proteoglycans (SLRPs) Are Involved in the Anti-Myeloma Response of Osteoblasts. Blood. 110: 815-815. DOI: 10.1182/Blood.V110.11.815.815 |
0.317 |
|
| 2007 |
Pennisi A, Li X, Zangari M, Sawyer JR, Zhan F, Barlogie B, Shaughnessy J, Yaccoby S. Exploitation of Novel Hyperdiploid and Nonhyperdiploid Myeloma Cell Lines for Studying Innovative Interventions for Myeloma and Its Associated Bone Disease. Blood. 110: 548-548. DOI: 10.1182/Blood.V110.11.548.548 |
0.31 |
|
| 2006 |
Yaccoby S, Dillon SR, Ling W, Perkins P, Tisdale JR, Pennisi A, Saha R, Li X, Barlogie B, Tricot G, Zhan F, Shaughnessy J. Atacicept (TACI-Ig) Inhibits Growth of TACIhigh Primary Myeloma Cells in SCID-Hu Mice. Blood. 108: 842-842. DOI: 10.1182/Blood.V108.11.842.842 |
0.306 |
|
| 2005 |
Qin L, Li X, Ko JK, Partridge NC. Parathyroid hormone uses multiple mechanisms to arrest the cell cycle progression of osteoblastic cells from G1 to S phase. The Journal of Biological Chemistry. 280: 3104-11. PMID 15513917 DOI: 10.1074/Jbc.M409846200 |
0.314 |
|
| Show low-probability matches. |